Drug intelligence / Profile preview

Ditylin-Biolik

Development stage
Unknown
Lead developer
Farmstandart-Biolik
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ditylin-Biolik (Дитилін-Біолік) is an approved depolarizing neuromuscular blocking agent developed and manufactured by Biolik Biopharmaceutical in Ukraine. Its active ingredient is suxamethonium iodide (also known as succinylcholine iodide), a small molecule that acts as a short-acting muscle relaxant. Structurally resembling two joined molecules of acetylcholine, it binds to nicotinic receptors at the neuromuscular junction, causing persistent depolarization of the motor endplate and subsequent skeletal muscle paralysis. It is primarily indicated for facilitating tracheal intubation, providing muscle relaxation during endoscopic procedures (such as bronchoscopy or esophagoscopy), and maintaining myoplegia during short surgical interventions.

Brand names
Ditylin-BiolikДитилін-Біолік
Other names
suxamethonium iodidesuccinylcholine iodide
02

Targets

Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on Ditylin-Biolik.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ditylin-Biolik.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call